Favipiravir therapy for patients with covid-19 pneumonia: An observational study
Pneumonia in patients with COVID-19 is sometimes severe and life-threatening, and currently there is no specific effective drug approved for COVID-19 treatment. Favipiravir is a pyrazine analog inhibiting RNA virus RNA dependent RNA polymerase with antiviral activity against SARS-CoV-2. An observati...
Saved in:
Main Authors: | Supawadee Suppadungsuk, Thananya Wongsinin, Sirawat Srichatrapimuk, Suppachok Kirdlarp, Kulapong Jayanama, Kanin Thammavaranucupt, Dhanesh Pitidhammabhorn, Sithakom Phusanti, Nithita Nanthatanti, Somnuek Sungkanuparph |
---|---|
Other Authors: | Faculty of Medicine Ramathibodi Hospital, Mahidol University |
Format: | Article |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/78454 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
The association between body mass index and severity of Coronavirus Disease 2019 (COVID-19): A cohort study
by: Kulapong Jayanama, et al.
Published: (2022) -
Spontaneous tension hemothorax in a severe COVID-19 patient receiving ECMO therapy: The other side of COVID-19-associated coagulopathy
by: Kanin Thammavaranucupt, et al.
Published: (2022) -
Pulmonary function and six-minute-walk test in patients after recovery from COVID-19: A prospective cohort study
by: Dararat Eksombatchai, et al.
Published: (2022) -
Clinical features of adult patients with a definite diagnosis of central nervous system tuberculosis in an endemic country: A 13-year retrospective review
by: Suppachok Kirdlarp, et al.
Published: (2020) -
Integrated therapy for HIV and cryptococcosis
by: Sirawat Srichatrapimuk, et al.
Published: (2018)